Biopolis Shared Facilities and Carl Zeiss Announce Strategic Partnership and Collaboration

The Biopolis Shared Facilities (BSF) of the Biomedical Sciences Institutes (BMSI), Agency for Science, Technology and Research (A*STAR) has inked a Memorandum of Understanding (MoU) with Carl Zeiss MicroImaging, a global market leader in microscopy solutions and systems for research, laboratories, routine and industrial applications.

The MoU formalizes a strategic partnership and collaboration which brings technology and scientific mind together to further boost life science research and education to the future generations in the science community.

The BSF Advanced Microscopic Imaging Laboratory is already equipped with a number of ZEISS high-end microscopy systems such as the High Speed Line Scanning 5LiveDuo that is being used in a variety of life science research projects and in supporting the Biopolis Scientific Community.

In this partnership, Carl Zeiss will work closely with the BSF Advanced Microscopic Imaging Laboratory to introduce cutting edge technology to the Biopolis research community with systems on a rotational basis. In the coming year, Carl Zeiss will equip the facility with two million-dollar light microscopy systems; the SR-SIM (Superresolution Structured Illumination Microscopy) and PAL-M (Photoactivated Localization Microscopy) for scientists to work with their experiments.

"This partnership will allow scientists at BSF to experience state of the art imaging capabilities, using the finest research equipment in Singapore" said Ven Raman, Managing Director of Carl Zeiss S.E.Asia & India.

“This MOU with Carl Zeiss marks a new milestone in BSF’s development. Having high-end equipment is only one part of the equation. We wish to harness all the advanced features and capabilities residing in the equipment that we have so that our customers can benefit from them. More importantly this collaboration with Carl Zeiss will enable our scientists to access the latest innovations to advance the research being done at Biopolis,” said Dr. Manjeet Singh, Deputy Director, BSF.

“This is an exciting collaboration which will help bring leading edge technology and know how to researchers in the Biopolis” said Dr. Sohail Ahmed, Principal Investigator, Institute of Medical Biology (IMB), A*STAR, and Scientific Advisor to the BSF Advanced Microscopic Imaging Laboratory.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Carl Zeiss Microscopy GmbH. (2023, April 20). Biopolis Shared Facilities and Carl Zeiss Announce Strategic Partnership and Collaboration. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=13625.

  • MLA

    Carl Zeiss Microscopy GmbH. "Biopolis Shared Facilities and Carl Zeiss Announce Strategic Partnership and Collaboration". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=13625>.

  • Chicago

    Carl Zeiss Microscopy GmbH. "Biopolis Shared Facilities and Carl Zeiss Announce Strategic Partnership and Collaboration". AZoNano. https://www.azonano.com/news.aspx?newsID=13625. (accessed November 21, 2024).

  • Harvard

    Carl Zeiss Microscopy GmbH. 2023. Biopolis Shared Facilities and Carl Zeiss Announce Strategic Partnership and Collaboration. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=13625.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.